House Insurance Committee advances five health‑insurance bills including prior‑authorization 'gold‑card' requirement

The Georgia House Insurance Committee advanced five health‑insurance measures during a committee hearing, approving on voice votes a Senate bill that would require insurers using prior authorization to implement a so‑called “gold card” program and four House bills addressing genetic testing for cancer, earlier prostate‑cancer screening for some men, insurer payment transparency and pretax health‑savings accounts for high‑deductible plans.

Senator Kirkpatrick, the Senate sponsor of Senate Bill 5, said, “This bill should look very familiar to you. It's very similar to a bill that we passed in the senate and the house last year,” and described the proposal as requiring health insurers that use prior authorization to maintain a gold‑card program and provide the program’s criteria to the Georgia Department of Insurance. Anna Rizika, who identified herself as a staff member with the Medical Association of Georgia, told the committee she spoke “on behalf of our members” to express “our strong support for this bill.” Jesse Wellington, president of the Georgia Association of Health Plans, also voiced support and thanked the sponsor for working with the industry.

The committee approved Senate Bill 5 on a voice vote after public testimony in favor and no recorded roll‑call. The bill would take effect Jan. 1, 2026, with a first filing due July 1, 2026, according to the sponsor’s remarks.

House Bill 420 (LC 520769S) was returned to the committee because earlier substitute copies were not distributed correctly; Representative Taylor explained the corrected text clarifies that genetic testing tied to a family member’s cancer diagnosis would be covered "as any other benefit," subject to the same deductible and copay structure as other covered benefits. The committee approved the corrected bill on a voice vote.

Representative Glaze presented House Bill 373, which he framed as a prostate‑cancer screening measure for men ages 40–49 who have family histories or other clinical indications. "This bill, just by virtue of a simple, definition, is just to save the lives of men who are between 40 to 49 years old," Glaze said. He cited state cancer incidence and mortality figures during his remarks and cited U.S. Cancer Society projections for 2025. Representative Hughley moved the bill do pass; it was approved by voice vote.

House Bill 170 (LC 520621), presented by Representative Matheak, would require insurers to provide providers, within 30 days, information about payments when a licensed health‑care provider makes a written request related to assignment of benefits. The sponsor described the measure as a transparency provision to help providers reconcile payments and said the language was moved into the correct part of Title 33. The committee approved the bill on a voice vote.

Representative McCullough presented House Bill 442 (LC 550485), which would allow pretax contributions to a health‑savings account for state high‑deductible plans. McCullough said changing to pretax treatment would reduce employer and employee payroll taxes (a 7.65 percent payroll‑tax savings he cited) and that departments were working on implementation details. Representative Davis asked whether the account would roll over; McCullough and members clarified that health‑savings accounts roll over and can accumulate year to year and that a family can contribute up to the statutory limits referenced in the discussion. Representative Hughley noted a fiscal note line item of $300,000 in one‑time marketing costs and said employee education is an implementation concern; the sponsor said human resources offices would be responsible for plan communications. Committee members discussed the bill’s proposed implementation date (an October 1, 2025 date appears in the bill text) and noted that departments may need more time to implement.

All measures were advanced by the committee on voice votes with no recorded roll‑call tallies in the hearing record presented to the committee. Committee staff were instructed to prepare the proper forms to forward the measures to the next legislative step.

Votes at a glance - Senate Bill 5 (prior authorization/gold‑card program): motion to do pass; outcome: approved (voice vote). Sponsor: Senator Kirkpatrick. Public testimony in favor from Medical Association of Georgia and Georgia Association of Health Plans. - House Bill 420 (genetic testing coverage tied to family cancer history, LC 520769S): motion to do pass; outcome: approved (voice vote). Sponsor: Representative Taylor (presented correction). - House Bill 373 (prostate‑cancer screening for ages 40–49, Title 33 change): motion to do pass (moved by Representative Hughley); outcome: approved (voice vote). Sponsor: Representative Glaze. - House Bill 170 (insurer payment disclosure to providers within 30 days, LC 520621): motion to do pass; outcome: approved (voice vote). Sponsor: Representative Matheak. - House Bill 442 (pretax health‑savings accounts for state high‑deductible plans, LC 550485): motion to do pass; outcome: approved (voice vote). Sponsor: Representative McCullough. Fiscal note discussed: $300,000 one‑time marketing cost noted in the bill packet.

Why this matters The measures target administrative burdens (prior authorization and payment transparency), preventive care access (genetic testing and prostate screening), and employee benefits design (pretax HSAs). If enacted, the prior‑authorization change would require insurers to formalize expedited approval pathways for providers who meet evidence‑based criteria; the transparency bill would give providers a timeline for obtaining payment‑disposition information; the prevention bills could change coverage and screening practice; and the HSA change could alter payroll‑tax treatment for state employees' accounts. Several bills require further work with state agencies to implement timelines and communications.

What’s next Committee staff will file the committee’s forms and forward the bills to the next step in the House process. For several measures—particularly the HSA pretax change and the genetic‑testing clarification—sponsors and state departments indicated that implementation details and enrollment timing may need additional coordination.